ANOMALY WEALTHMutual Fund Intelligence Data throughAug 2026 Trade Intelligence ↗

Comparable monthly disclosures

Institutional Activity

Where disclosed mutual fund positions are increasing, reducing, opening or closing.

Breadth contraction

Oct 2022 · Ranked across companies with at least 10 comparable portfolios

Sorting and search apply to this page of 25. Change pages to explore further down the ranking.
Company AMC breadth change Comparable change Portfolios increasing Portfolios reducing Comparable portfolios
Steel Authority of India Limited SAIL -6 of 5 AMCs -0.43 Cr 6 5 27
Mahindra & Mahindra Financial Services Limited M&MFIN -6 of 6 AMCs +0.50 Cr 9 2 33
PVR INOX Limited PVRINOX -5 of 6 AMCs -41,789 6 2 27
NMDC Limited NMDC -5 of 9 AMCs -1.72 Cr 2 4 28
Metropolis Healthcare Limited METROPOLIS -3 of 5 AMCs -0.01 Cr 2 5 19
National Aluminium Company Limited NATIONALUM -3 of 7 AMCs -0.63 Cr 6 4 25
Hero MotoCorp Limited HEROMOTOCO -3 of 11 AMCs -0.05 Cr 22 15 74
Canara Bank CANBK -3 of 9 AMCs -0.11 Cr 10 8 55
Aarti Industries Limited AARTIIND -3 of 3 AMCs -0.03 Cr 5 0 16
Dalmia Bharat Limited DALBHARAT -2 of 8 AMCs +59,942 9 2 31
Zydus Lifesciences Limited ZYDUSLIFE -2 of 10 AMCs +0.11 Cr 7 8 29
SBI Cards and Payment Services Limited SBICARD -2 of 11 AMCs +0.03 Cr 22 6 84
REC Limited RECLTD -2 of 6 AMCs -0.07 Cr 5 4 13
SHREE CEMENT LIMITED SHREECEM -2 of 7 AMCs -2,572 8 4 37
Dr. Reddy's Laboratories Limited DRREDDY -2 of 12 AMCs -0.02 Cr 20 29 88
Oberoi Realty Limited OBEROIRLTY -2 of 10 AMCs +0.08 Cr 18 3 39
Piramal Pharma Limited PPLPHARMA -2 of 2 AMCs +0.60 Cr 0 0 11
Godrej Consumer Products Limited GODREJCP -2 of 10 AMCs -0.01 Cr 18 10 54
Bajaj Holdings & Investment Limited BAJAJHLDNG -2 of 8 AMCs -54 8 3 17
Punjab National Bank PNB -2 of 8 AMCs +3.83 Cr 21 8 32
Havells India Limited HAVELLS -2 of 10 AMCs -0.03 Cr 11 13 42
Max Financial Services Limited MFSL -2 of 10 AMCs +0.02 Cr 11 3 47
Bosch Limited BOSCHLTD -2 of 10 AMCs +9,149 17 5 46
The Ramco Cements Limited RAMCOCEM -2 of 9 AMCs -0.11 Cr 4 3 27
Aurobindo Pharma Limited AUROPHARMA -2 of 8 AMCs -0.02 Cr 9 5 30
How to read this activity

Activity compares disclosed positions for economic portfolios observed in both relevant monthly disclosures and adjusts for externally evidenced corporate actions where available.

At least 10 comparable portfolios are required. Companies under corporate-action review are excluded. Counts are unweighted by portfolio size, and share changes are quantities rather than market values; zero counts can appear at the end of a ranking. Breadth change is the change in AMCs holding, and can also reflect reporting coverage.

Full methodology →